SCHEMBL4860916

SCHEMBL4860916

CCOc1ccccc1OCCN(CCCCC(=O)c1ccc2c(c1)n(C)c(=O)n2C)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GLA P06280 1/20 0.42
BRPF1 P55201 2/20 0.40
TP53 P04637 2/20 0.38
THRA P10827 3/20 0.38
THRB P10828 2/20 0.38
HTT P42858 1/20 0.38
BRD4 O60885 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
POLB P06746 2/20 0.37
CASP6 P55212 1/20 0.37
MAPT P10636 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4856758 0.89 BRPF1 (0.37) ALDH1A1SMN1; SMN2GLABRPF1TP53
SCHEMBL4860032 0.87 LMNA (0.40) ALDH1A1SMN1; SMN2GLABRPF1TP53
SCHEMBL6035325 0.83 HTR1A (0.44) ALDH1A1SMN1; SMN2GLABRPF1TP53
Hydrochloric Acid SCHEMBL4862688 0.82 HTR1A (0.45) ALDH1A1SMN1; SMN2GLABRPF1TP53
SCHEMBL4854944 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2GLABRPF1HTT
SCHEMBL4861407 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2GLABRPF1HTT
SCHEMBL4860764 0.81 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2GLABRPF1TP53
SCHEMBL4851970 0.80 CYP19A1 (0.40) TP53THRATHRBKDM4EPOLB
SCHEMBL4858446 0.79 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2GLABRPF1HTT
SCHEMBL4862399 0.77 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2GLABRPF1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed
US-7138533-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-11-21 US disclosed
US-7132547-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-11-07 US disclosed
US-20060211675-A1 Preventives/remedies for urinary disturbance ISHIHARA YUJI 2006-09-21 US disclosed
US-20060063769-A1 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-03-23 US disclosed
US-20050197362-A1 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-08 US disclosed
EP-1466625-A1 PREVENTIVES/REMEDIES FOR URINARY DISTURBANCE Takeda Chemical Industries, Ltd. (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063769-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, CHRM1 ALDH1A1 118/4885SMN1; SMN2 1472/4885GLA 193/4885
US-20050197362-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, CHRM1 ALDH1A1 118/4885SMN1; SMN2 1472/4885GLA 193/4885
US-20060211675-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, ACE ALDH1A1 212/4885SMN1; SMN2 1418/4885GLA 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.